I-Antihistamine "Tavegil": izinkomba zokusetshenziswa

Omunye wemithi ethandwa kakhulu ezweni lakithi ukulwa nezimpawu zokungezwani komzimba nguTavegil. Izimpawu zokusetshenziswa kwalesi sidakamizwa zihluke kakhulu. Izenzo ziyinto esheshayo futhi ayinayo imiphumela emibi eminingi. Mayelana nale antihistamine kusho ukuthi sizoqhubeka.

Incazelo yesidakamizwa "Tavegil"

Isithako esikhulu esisebenzayo salesi sidakamizwa si-clemastine fumarate. Le-ejenti yi-derivative ye-ethanolamine futhi ineziphumo ezilandelayo emzimbeni womuntu:

- kunciphisa ukuguqulwa kwama-capillaries kanye nemikhumbi;

- kusiza ukunciphisa ukutshaya;

- kuvimbela ukwakheka kwe-edema;

- ukhiqiza umphumela wokuguqula ;

- kuvimbela ukukhishwa kwemisipha ebushelelezi;

- unomthelela we-anesthetic wendawo.

Kubantu abaningi abanesifo sofuba, kubaluleke kakhulu ukuthi lesi sidakamizwa asinomphumela wokubamba. Lezi zidingo zihambelana nomuthi "Tavegil": izinkomba zokusetshenziswa zivumela ukuthi zisetshenziswe ngisho nabashayeli, abasebenzi kanye nabaqhubi bezinqubo ezehlukene. Kule ndaba, ungathatha lo muthi ngokuphepha, ngaphandle kokukhathazeka ukuthi uzobe ulele.

Isidakamizwa esithi "Tavegil": izinkomba zokusetshenziswa

Lesi sidakamizwa, esitholakala ngendlela yamathebhulethi nesiraphu, sinconywa ukuthi sisetshenziswe ku-dermatoses, imifuba, i-rhinitis, i-dermatitis, i-hay fever, i-eczema, ukusabela okubangelwa ukuphuza imithi nokulunywa kwezidakamizwa. Ama-injection aboniswa ukugula kwe- serum, i- angioedema, i- vasculitis enegazi, ukuphendula kwe-anaphylactoid (ikakhulukazi, ukushuswa kwe-anaphylactic), i-iridocyclitis enzima, kanye nasempilweni ye-pseudoallergic ne-allergenic. Ngakho-ke, lesi sidakamizwa "i-Tavegil", izinkomba zokusetshenziswa okubandakanya izimo eziningi ezahlukene, zingabizwa ngokuphepha ngokuthi i-antihistamine yonke. Kodwa-ke, njengezidakamizwa eziningi, akufanelekele ukusetshenziswa yizo zonke iziguli. Ngakho-ke, ungasebenzisi lesi sidakamizwa esithi "Tavegil" phambi kwezimo ezilandelayo: izifo eziphansi zokuphefumula, isifo se-asthma, i-zakratougolnaya glaucoma, i-hyperplasia e-prostatic, i-stenosis ye-pylorus, thyrotoxicosis nomfutho wegazi ophezulu. Futhi, akufanele uthathe le mithi kubesifazane abasesimweni esithakazelisayo nokuncelisa. Ngaphezu kwalokho, akuyona into engathandeki ukuhlanganisa ukwamukela kwakhe ngotshwala kanye ne-monoamine oxidase inhibitors.

Isidakamizwa "Tavegil": isilinganiso

Lesi sidakamizwa ngesimo samathebulethi sithatha isikhathi sasekuseni nasokuhlwa sika-1 mg. Endabeni yokungezwani okukhulu, ukwanda komthamo wansuku zonke kuvunyelwe, kepha kungaphezu kokuphindwe kabili. Izingane ezineminyaka engama-6 kuya kwengu-12 zinconywa ukuba zithathe isigamu somthamo womuntu omdala. Umthamo wansuku zonke we-"Tavegil" isiraphu kumuntu omdala ungama-20ml (10 ml ekuseni nakusihlwa), wengane eneminyaka engu-3 kuya kwengu-12 - 10 ml, kanye nengane kuze kube yiminyaka emithathu - 2 ml.